General MedicationsOPHTHALMICStandard
LOTEMAX
LOTEPREDNOL ETABONATE
Standard Dose
0.5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview LOTEMAX is listed in Drugs@FDA under application 200738 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LOTEPREDNOL ETABONATE Form and strength OINTMENT;OPHTHALMIC - 0.5% Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 2020-12-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview LOTEMAX is listed in Drugs@FDA under application 200738 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LOTEPREDNOL ETABONATE Form and strength OINTMENT;OPHTHALMIC - 0.5% Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 2020-12-08 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.